Newsfeeds Archive - Spark Newswire

1 minute read

FDA Mandates “Boxed Warning” For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therapies

April 19, 9:28 AM

Following an investigation announced in November last year, the FDA said on Thursday that it would now require boxed warnings—the highest safety-rel

BMY

2 minute read

FDA Approves Bristol-Myers/2seventy Bio’s Abecma For Earlier Use In Pretreated Blood Cancer Patients With Updated Boxed Warning On Secondary Cancer

By Vandana Singh

April 5, 1:37 PM

FDA approves Bristol-Myers Squibb and 2seventy Bio Abecma (ide-cel) for relapsed or refractory multiple myeloma after ≥2 prior therapies. Extends progression-free survival by 13.3 months vs. standard care.

BMY

3 minute read

U.S. FDA Approves Bristol Myers Squibb And 2seventy bio’s Abecma For Triple-Class Exposed Relapsed Or Refractory Multiple Myeloma After Two Prior Lines Of Therapy; Abecma Tripled Progression-Free Survival Compared To Standard Regimens In The Phase 3 Ka…

By Benzinga Newsdesk

April 5, 9:07 AM

Abecma tripled progression-free survival compared to standard regimens in the Phase 3 KarMMa-3 trial, with a 51% reduction in risk of disease progression or death and a well-established safety profileExpanded approval

BMY

2 minute read

Why Is Sanofi Partner Regeneron Pharmaceuticals Stock Trading Higher Today?

By Vandana Singh

February 2, 12:08 PM

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) reported fourth-quarter adjusted EPS of $11.86, down 6% Y/Y, beating the consensus of $10.77.

REGN

4 minute read

Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session

By Avi Kapoor

January 31, 2:18 PM

Shares of Advanced Micro Devices, Inc. (NASDAQ: AMD) shares declined 3.8% to $165.49 following fourth-quarter results. AMD reported fourth-quarter non-GAAP earnings per share of 77 cents per share on revenue of $6.17 billion. AMD shares dipped 3.8% to $165.49 on Wednesday.

AHT

1 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s Intraday Session

By Benzinga Insights

January 31, 1:31 PM

Gainers Sonoma Pharmaceuticals (NASDAQ:SNOA) shares moved upwards by 36.0% to $0.21 during Wednesday’s regular session. The market value…

EVAX

3 minute read

Crude Oil Down 2%; Alphabet Shares Fall After Q4 Results

By Avi Kapoor

January 31, 1:11 PM

U.S. stocks traded mostly lower midway through trading, with the Nasdaq Composite falling more than 200 points on Wednesday. The Dow traded up 0.08% to 38,497.13 while the NASDAQ fell 1.41% to 15,291.02. The S&P 500 also fell, dropping, 0.81% to 4,885.29.

GNPX

1 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s Intraday Session

By Benzinga Insights

January 30, 1:31 PM

Gainers NexImmune (NASDAQ:NEXI) stock increased by 152.8% to $23.51 during Tuesday’s regular session. The company’s market cap stands…

ADXN

1 minute read

FDA
News

FDA Reported Monday It Is Requiring Boxed Warning For CAR-T Cancer Therapies

By Charles Gross

January 23, 6:13 AM

https://www.fda.gov/media/175627/download?attachment https://www.fda.gov/media/175626/download?attachment https://www.fda.gov/media/175625/download?attachment https://www.fda.gov/media/175624/download?attachment https://www.fda.gov/media/175622/download?attachment https://www.fda.gov/media/175623/download?attachment

BMY

1 minute read

News

JW Therapeutics Announces Exclusive Collaboration with 2seventy bio for Autoimmune Disease CAR-T Therapy

By Benzinga Newsdesk

January 2, 8:29 AM

JW Therapeutics (HKEx: 2126), an independent innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy products, is pleased to announce an exclusive collaboration with

TSVT